# Rigshospitalet, Copenhagen University Hospital

Source: https://onco.cc/institutions/rigshospitalet/  
OnCo record `rigshospitalet` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Denmark's national referral hospital, a leading Nordic centre for haematology, phase 1 trials and, with Herlev, tumour-infiltrating lymphocyte therapy.

## Summary

Rigshospitalet is Denmark's national referral hospital for specialised care and the largest partner in the Danish Comprehensive Cancer Center. Its haematology department under Kirsten Grønbæk and colleagues leads Danish and Nordic leukaemia and lymphoma trials and CAR-T delivery, the phase 1 unit under Ulrik Lassen runs the Copenhagen Prospective Personalized Oncology programme, and radiation oncology has a long record in lymphoma and breast radiotherapy trials. Copenhagen University Hospital's Herlev site hosts the National Center for Cancer Immune Therapy (CCIT-DK, Inge Marie Svane), which co-led the phase 3 trial of TIL therapy in melanoma with the Netherlands Cancer Institute. Denmark's population registries and biobanks make the hospital a hub for real-world and epidemiological cancer research.

## Fields

- Kind: Institution
- Last checked: 2026-09-09
- Also known as: Rigshospitalet; Copenhagen University Hospital; Copenhagen Comprehensive Cancer Center; Copenhagen Comprehensive Cancer Center (CCCC)
- City: Copenhagen, DK
- Type: hospital
- Website: https://www.rigshospitalet.dk/english

## Sources

- Homepage: https://www.rigshospitalet.dk/english
- Danish Comprehensive Cancer Center: https://www.dccc.dk/english/
- CCIT-DK: https://www.herlevhospital.dk/ccit-dk/

## Connected records

- cancers: [Acute myeloid leukaemia](https://onco.cc/cancers/aml/), [Chronic lymphocytic leukaemia](https://onco.cc/cancers/cll/), [Diffuse large B-cell lymphoma](https://onco.cc/cancers/dlbcl/), [Melanoma](https://onco.cc/cancers/melanoma/), [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/)
- fronts: [Cell Therapy](https://onco.cc/fronts/cell-therapy/), [Immunotherapy](https://onco.cc/fronts/immunotherapy/)
- technologies: [CAR-T cell therapy](https://onco.cc/technologies/car-t/), [Comprehensive genomic profiling](https://onco.cc/technologies/cgp/), [IMRT / IGRT (modern external beam)](https://onco.cc/technologies/imrt-igrt/), [TIL therapy](https://onco.cc/technologies/til-therapy/)
- institutions: [Aalborg University Hospital](https://onco.cc/institutions/aalborg-university-hospital/), [Aarhus University Hospital](https://onco.cc/institutions/aarhus-university-hospital/), [Herlev Hospital, Copenhagen University Hospital](https://onco.cc/institutions/herlev-hospital/), [Landspítali, the National University Hospital of Iceland](https://onco.cc/institutions/landspitali/), [Netherlands Cancer Institute (NKI-AvL)](https://onco.cc/institutions/nki/), [Odense University Hospital](https://onco.cc/institutions/odense-university-hospital/), [Zealand University Hospital](https://onco.cc/institutions/zealand-university-hospital/)
- terms: [Real-world evidence](https://onco.cc/terms/real-world-evidence/)
- people: [Jannick Brennum](https://onco.cc/people/jannick-brennum/), [Mansoor Raza Mirza](https://onco.cc/people/mansoor-raza-mirza/), [Rasmus Møgelvang](https://onco.cc/people/rasmus-mogelvang/)
- bottlenecks: [Weak real-world evidence and registries](https://onco.cc/bottlenecks/b-real-world-evidence/)
- companies: [Danish Breast Cancer Group](https://onco.cc/companies/dbcg/)

---
JSON: https://onco.cc/api/v1/entities/rigshospitalet.json